Grant Support

Current Support

NIH/NIAID & Indiana University (R01 AI180448), “Development of allergy in offspring is enhanced by maternal eicosanoids and lung microbiota composition dysbiosis” (2023-2028).  Seroogy, Co-Investigator

NIH/NIA (U01 AG076941), “Clinical evaluation of mTORC1 inhibition for geroprotection” (2022-2028).  Seroogy, Co-Investigator

NIH/NIAID (U19 AI104317), “Interactions between the microbiome, immunity and respiratory health in traditional agrarian and suburban childre; Viral and environmental determinants of rhinovirus illness severity” (2013-2028).  Seroogy, MPI

NIH/Office of the Director (UG3/UH3 OD023282), “Wisconsin infant study cohort (WISC) ECHO pediatric follow-up; Children’s respiratory and environmental workgroup (CREW)” (2016-2026). Seroogy, Co-Investigator

Completed Support

NIH/NIAID (U24 AI152177), “A multiplexed micro scale assay for real time analysis of pediatric immune cell function” (2020-2025).  Seroogy, Co-Investigator

Hatch Act Formula Fund, “Impact of infant milk composition on early childhood allergic disease” (2020-2024).  Seroogy, Co-Investigator

NIH & University of California-San Diego, “Trajectory of B cell receptor maturation during the first two years of life in the WISC birth cohort” (2022-2023).  Seroogy, supplement PI

Ira and Ineva Reilly Baldwin Wisconsin Idea Endowment, “Development and implementation of rapid genetic test to improve health outcomes in Wisconsin plain newborns” (2018-2023). Seroogy, PI

Wisconsin Partnership Program, “Integrated metabolomics, microbial genomics and immune profiling in early infancy to identify biomarkers for allergic disease prevention” (2018-2022).  Seroogy, PI

NIH/NIAID & Indiana University, “Lipid regulation of the development of responsiveness to allergen in neonates and infants” (2017-2021).  Seroogy, Co-Investigator

Wisconsin Partnership Program, “Improved health care delivery to Wisconsin amish infants” (2014-2017).  Seroogy, PI

NIH/NHLBI (P01 HL070831), “COAST – Rhinovirus infections and asthma in children and adolescents ” (2013-2019).  Seroogy, Project 1 Co-Investigator

Baldwin Wisconsin Idea Endowment, “Blood level testing in plain newborns” (2017-2019).  Seroogy, PI

NIH/NCI (P30 CA014520), “The role of the anergy-related E3 ubiquitin ligase, GRAIL, in tumor immune evasion” (2015-2017).  Seroogy, pilot grant PI

Midwest Athletes Against Childhood Cancer (MACC fund), “The gene related to anergy in lymphocytes, GRAIL, and its implications in tumor anergy” (2004-2017).  Seroogy, PI

CDC & Upper Midwest Agricultural Safety and Health Center, “Exploratory immunologic differences in cord blood from infants born into farming environments compared to nonfarming environments in MESA” (2012-2014).  Seroogy, pilot grant PI

Wisconsin Partnership Program, “Novel exploratory approaches to elucidating the role of GRAIL in CD25+ T regulatory cell biological function” (2006-2008).  Seroogy, PI

NIH/NIAID (R21 AI064234), “Role of GRAIL in CD25+ T regulatory cells” (2005-2008).  Seroogy, PI